291 related articles for article (PubMed ID: 29207183)
1. Src homology phosphotyrosyl phosphatase 2 mediates cisplatin-related drug resistance by inhibiting apoptosis and activating the Ras/PI3K/Akt1/survivin pathway in lung cancer cells.
Tang C; Luo H; Luo D; Yang H; Zhou X
Oncol Rep; 2018 Feb; 39(2):611-618. PubMed ID: 29207183
[TBL] [Abstract][Full Text] [Related]
2. Periostin Contributes to Cisplatin Resistance in Human Non-Small Cell Lung Cancer A549 Cells via Activation of Stat3 and Akt and Upregulation of Survivin.
Hu W; Jin P; Liu W
Cell Physiol Biochem; 2016; 38(3):1199-208. PubMed ID: 26982182
[TBL] [Abstract][Full Text] [Related]
3. [Effect of down-regulation of survivin gene on apoptosis and cisplatin resistance in cisplatin resistant human lung adenocarcinoma A549/CDDP cells].
Zhang MC; Hu CP; Chen Q
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):408-12. PubMed ID: 17152483
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.
Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X
FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223
[TBL] [Abstract][Full Text] [Related]
5. Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling.
Wang HJ; Yang ZX; Dai XT; Chen YF; Yang HP; Zhou XD
Apoptosis; 2017 Sep; 22(9):1157-1168. PubMed ID: 28677094
[TBL] [Abstract][Full Text] [Related]
6. AKT1 amplification regulates cisplatin resistance in human lung cancer cells through the mammalian target of rapamycin/p70S6K1 pathway.
Liu LZ; Zhou XD; Qian G; Shi X; Fang J; Jiang BH
Cancer Res; 2007 Jul; 67(13):6325-32. PubMed ID: 17616691
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between survivin expression and chemosensitivity of human lung cancer cells].
Yang H; Fu JH; Hu Y; Huang WZ; Zheng B; Wang G
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(27):1934-7. PubMed ID: 17923022
[TBL] [Abstract][Full Text] [Related]
8. HtrA1 downregulation induces cisplatin resistance in lung adenocarcinoma by promoting cancer stem cell-like properties.
Xu Y; Jiang Z; Zhang Z; Sun N; Zhang M; Xie J; Li T; Hou Y; Wu D
J Cell Biochem; 2014 Jun; 115(6):1112-21. PubMed ID: 24356998
[TBL] [Abstract][Full Text] [Related]
9. Shp2 confers cisplatin resistance in small cell lung cancer via an AKT-mediated increase in CA916798.
Yang X; Tang C; Luo H; Wang H; Zhou X
Oncotarget; 2017 Apr; 8(14):23664-23674. PubMed ID: 28423588
[TBL] [Abstract][Full Text] [Related]
10. [Wogonoside reverses cisplatin resistance in SGC7901/cDDP cells through inhibition of PI3K/Akt/Nrf2/ARE signaling pathway].
Wang LJ; Wang SG; Deng TX
Sheng Li Xue Bao; 2018 Aug; 70(4):397-405. PubMed ID: 30112565
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin resistance in lung cancer is mediated by MACC1 expression through PI3K/AKT signaling pathway activation.
Zhang Q; Zhang B; Sun L; Yan Q; Zhang Y; Zhang Z; Su Y; Wang C
Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):748-756. PubMed ID: 29961813
[TBL] [Abstract][Full Text] [Related]
12. Influence of SiRNA targeting survivin on chemosensitivity of H460/cDDP lung cancer cells.
Yang H; Fu JH; Hu Y; Huang WZ; Zheng B; Wang G; Zhang X; Wen J
J Int Med Res; 2008; 36(4):734-47. PubMed ID: 18652770
[TBL] [Abstract][Full Text] [Related]
13. Par-4 downregulation confers cisplatin resistance in pancreatic cancer cells via PI3K/Akt pathway-dependent EMT.
Tan J; You Y; Xu T; Yu P; Wu D; Deng H; Zhang Y; Bie P
Toxicol Lett; 2014 Jan; 224(1):7-15. PubMed ID: 24144893
[TBL] [Abstract][Full Text] [Related]
14. Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line.
Lee S; Choi EJ; Jin C; Kim DH
Gynecol Oncol; 2005 Apr; 97(1):26-34. PubMed ID: 15790433
[TBL] [Abstract][Full Text] [Related]
15. HtrA1 Down-regulation Induces Cisplatin Resistance in Colon Cancer by Increasing XIAP and Activating PI3K/Akt Pathway.
Xiong Z; Fu Z; Shi J; Jiang X; Wan H
Ann Clin Lab Sci; 2017 May; 47(3):264-270. PubMed ID: 28667026
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin activates Akt in small cell lung cancer cells and attenuates apoptosis by survivin upregulation.
Belyanskaya LL; Hopkins-Donaldson S; Kurtz S; Simões-Wüst AP; Yousefi S; Simon HU; Stahel R; Zangemeister-Wittke U
Int J Cancer; 2005 Dec; 117(5):755-63. PubMed ID: 15981204
[TBL] [Abstract][Full Text] [Related]
17. Gallic acid induces apoptosis and enhances the anticancer effects of cisplatin in human small cell lung cancer H446 cell line via the ROS-dependent mitochondrial apoptotic pathway.
Wang R; Ma L; Weng D; Yao J; Liu X; Jin F
Oncol Rep; 2016 May; 35(5):3075-83. PubMed ID: 26987028
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol inhibits viability and induces apoptosis in the small‑cell lung cancer H446 cell line via the PI3K/Akt/c‑Myc pathway.
Li W; Li C; Ma L; Jin F
Oncol Rep; 2020 Nov; 44(5):1821-1830. PubMed ID: 32901891
[TBL] [Abstract][Full Text] [Related]
19. PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways.
Fu X; Feng J; Zeng D; Ding Y; Yu C; Yang B
Biosci Rep; 2014 Apr; 34(2):. PubMed ID: 27919028
[TBL] [Abstract][Full Text] [Related]
20. IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/Akt pathway in non-small cell lung cancer.
Cortés-Sempere M; de Miguel MP; Pernía O; Rodriguez C; de Castro Carpeño J; Nistal M; Conde E; López-Ríos F; Belda-Iniesta C; Perona R; Ibanez de Caceres I
Oncogene; 2013 Mar; 32(10):1274-83. PubMed ID: 22543588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
